Original Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 745-754
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.745
Figure 1
Figure 1 Study design. A total of 129 patients with Barcelona Clinic Liver Cancer (BCLC) stage 0 (n = 40) and stage A hepatocellular carcinoma (HCC) (n = 89) who underwent transarterial chemoembolization (TACE) were retrospectively enrolled. Op: Operation.